Campbell, K., Rodino-Klapac, L., Sahenk, Z., Shilling, C., Lewis, S., Bowles, D., … Walker, C. (2010). Revertant muscle fibers expressing dystrophin do not tolerize the immune system in Duchenne muscular dystrophy: lessons learned from a Phase I clinical trial. In JOURNAL OF IMMUNOLOGY (Vol. 184). AMER ASSOC IMMUNOLOGISTS.

Campbell, Katherine, Louise Rodino-Klapac, Zarife Sahenk, Chris Shilling, Sarah Lewis, Dawn Bowles, Steven Gray, et al. “Revertant muscle fibers expressing dystrophin do not tolerize the immune system in Duchenne muscular dystrophy: lessons learned from a Phase I clinical trial.” In JOURNAL OF IMMUNOLOGY, Vol. 184. AMER ASSOC IMMUNOLOGISTS, 2010.

Campbell K, Rodino-Klapac L, Sahenk Z, Shilling C, Lewis S, Bowles D, et al. Revertant muscle fibers expressing dystrophin do not tolerize the immune system in Duchenne muscular dystrophy: lessons learned from a Phase I clinical trial. In: JOURNAL OF IMMUNOLOGY. AMER ASSOC IMMUNOLOGISTS; 2010.

Campbell, Katherine, et al. “Revertant muscle fibers expressing dystrophin do not tolerize the immune system in Duchenne muscular dystrophy: lessons learned from a Phase I clinical trial.” JOURNAL OF IMMUNOLOGY, vol. 184, AMER ASSOC IMMUNOLOGISTS, 2010.

Campbell K, Rodino-Klapac L, Sahenk Z, Shilling C, Lewis S, Bowles D, Gray S, Li C, Galloway G, Malik V, Coley B, Clark R, Li J, Xiao X, Samulski J, McPhee S, Samulski RJ, Mendell J, Walker C. Revertant muscle fibers expressing dystrophin do not tolerize the immune system in Duchenne muscular dystrophy: lessons learned from a Phase I clinical trial. JOURNAL OF IMMUNOLOGY. AMER ASSOC IMMUNOLOGISTS; 2010.